G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 120 filers reported holding G1 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 58.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,813,321 | -55.2% | 333,945 | +3.1% | 0.48% | -55.6% |
| Q3 2022 | $4,046,000 | +6.8% | 323,945 | -57.8% | 1.09% | -24.8% |
| Q2 2022 | $3,790,000 | +2.0% | 767,235 | +57.0% | 1.45% | -8.4% |
| Q1 2022 | $3,714,000 | +58.2% | 488,635 | +112.4% | 1.58% | +102.7% |
| Q4 2021 | $2,348,000 | +249.9% | 230,000 | +360.0% | 0.78% | +297.4% |
| Q3 2021 | $671,000 | -38.8% | 50,000 | 0.0% | 0.20% | -23.1% |
| Q2 2021 | $1,097,000 | -8.8% | 50,000 | 0.0% | 0.26% | +5.8% |
| Q1 2021 | $1,203,000 | +7.9% | 50,000 | -19.4% | 0.24% | -23.2% |
| Q4 2020 | $1,115,000 | +14.9% | 62,000 | -26.2% | 0.31% | -9.0% |
| Q3 2020 | $970,000 | -9.1% | 84,000 | +90.9% | 0.34% | -17.1% |
| Q2 2020 | $1,067,000 | – | 44,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |